OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains
- PMID: 30348663
- PMCID: PMC6325231
- DOI: 10.1128/AAC.01676-18
OXA-23 Is a Prevalent Mechanism Contributing to Sulbactam Resistance in Diverse Acinetobacter baumannii Clinical Strains
Keywords: Acinetobacter baumannii; OXA-23; resistance mechanism; sulbactam.
Figures

Similar articles
-
Emergence of OXA-72-producing Acinetobacter baumannii Belonging to High-Risk Clones (CC15 and CC79) in Different Brazilian States.Infect Control Hosp Epidemiol. 2017 Feb;38(2):252-254. doi: 10.1017/ice.2016.287. Epub 2016 Dec 6. Infect Control Hosp Epidemiol. 2017. PMID: 27919299 No abstract available.
-
[Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].Mikrobiyol Bul. 2014 Jul;48(3):365-76. Mikrobiyol Bul. 2014. PMID: 25052103 Turkish.
-
[Evaluation of the efficacy of colistin/sulbactam combination on carbapenem-resistant Acinetobacter baumannii strains].Mikrobiyol Bul. 2016 Jul;50(3):460-5. doi: 10.5578/mb.26289. Mikrobiyol Bul. 2016. PMID: 27525401 Turkish.
-
Genetic basis of antibiotic resistance in pathogenic Acinetobacter species.IUBMB Life. 2011 Dec;63(12):1061-7. doi: 10.1002/iub.532. Epub 2011 Oct 12. IUBMB Life. 2011. PMID: 21990280 Review.
-
Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii.Future Microbiol. 2024;19(7):563-576. doi: 10.2217/fmb-2023-0248. Epub 2024 Mar 1. Future Microbiol. 2024. PMID: 38426849 Free PMC article. Review.
Cited by
-
Dual Role of gnaA in Antibiotic Resistance and Virulence in Acinetobacter baumannii.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e00694-19. doi: 10.1128/AAC.00694-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31358579 Free PMC article.
-
Metabolomics revealed mechanism for the synergistic effect of sulbactam, polymyxin-B and amikacin combination against Acinetobacter baumannii.Front Microbiol. 2023 Jun 29;14:1217270. doi: 10.3389/fmicb.2023.1217270. eCollection 2023. Front Microbiol. 2023. PMID: 37455727 Free PMC article.
-
Comparative Study of Different Diagnostic Routine Methods for the Identification of Acinetobacter radioresistens.Microorganisms. 2022 Aug 31;10(9):1767. doi: 10.3390/microorganisms10091767. Microorganisms. 2022. PMID: 36144369 Free PMC article.
-
Distribution and molecular characterization of carbapenemase-producing gram-negative bacteria in Henan, China.Sci Rep. 2024 Jun 22;14(1):14418. doi: 10.1038/s41598-024-65106-0. Sci Rep. 2024. PMID: 38909136 Free PMC article.
-
Beta-Lactamase Gene Expression Level of Hospital-Acquired CRAB Isolated from Children in Picu.Infect Drug Resist. 2021 Aug 16;14:3195-3205. doi: 10.2147/IDR.S322604. eCollection 2021. Infect Drug Resist. 2021. PMID: 34429619 Free PMC article.
References
-
- Hu FP, Guo Y, Zhu DM, Wang F, Jiang XF, Xu YC, Zhang XJ, Zhang CX, Ji P, Xie Y, Kang M, Wang CQ, Wang AM, Xu YH, Shen JL, Sun ZY, Chen ZJ, Ni YX, Sun JY, Chu YZ, Tian SF, Hu ZD, Li J, Yu YS, Lin J, Shan B, Du Y, Han Y, Guo S, Wei LH, Wu L, Zhang H, Kong J, Hu YJ, Ai XM, Zhuo C, Su DH, Yang Q, Jia B, Huang W. 2016. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. Clin Microbiol Infect 22:S9–S14. doi:10.1016/j.cmi.2016.01.001. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical